Activity — Definium Therapeutics, Inc.

13 moves.

Date	Actor	Action	Security	Value	Shares Δ	Position after	Impact
Jun 25, 2026	Sullivan Mark Executive	Sell	Common Shares	$585.8K	-13K -3.90%	320,571 0.24% of shares	medium
Mar 25, 2026	Barrow Robert CEO	Sell	Common Shares	$451.2K	-24K -3.14%	752,454 0.56% of shares	medium
Mar 25, 2026	Sullivan Mark Executive	Sell	Common Shares	$197.7K	-11K -3.80%	271,079 0.20% of shares	medium
Mar 25, 2026	Karlin Daniel Executive	Sell	Common Shares	$148.1K	-8K -1.90%	413,317 0.31% of shares	medium
Jun 22, 2026	Sullivan Mark Executive	Grant	Common Shares	$0	+63K +23.06%	333,579 0.25% of shares	low
Jun 11, 2026	Gryska David W Director	Grant	Common Shares	$0	+5K +30.63%	19,900 0.01% of shares	low
Feb 3, 2026	Wiley Matthew T. Executive	Grant	Common Shares	$0	+115K	115,000 0.09% of shares	low
Feb 3, 2026	Roberts Brandi Executive	Grant	Common Shares	$0	+150K	150,000 0.11% of shares	low
Feb 3, 2026	Sullivan Mark Executive	Grant	Common Shares	$0	+125K +44.24%	407,576 0.30% of shares	low
Feb 3, 2026	Karlin Daniel Executive	Grant	Common Shares	$0	+150K +35.29%	575,025 0.43% of shares	low
Feb 3, 2026	Barrow Robert CEO	Grant	Common Shares	$0	+320K +41.11%	1,098,477 0.82% of shares	low
Jun 11, 2026	Gryska David W Director	Grant	Stock Option (Right to Buy)	—	+19K	19,188 0.01% of shares	low
Jan 29, 2026	Adsett Roger Director	Grant	Stock Option (Right to Buy)	—	+50K	50,000 0.04% of shares	low